Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
GTI Energy

Related Posts

Top 5 Canadian Mining Stocks This Week: Euro...

April 1, 2025

Mali Approves New Gold Deals Under Revised Code

September 23, 2025

Lobo Tiggre: Gold, Oil in Times of War,...

March 6, 2026

Mario Innecco: Gold Still in Third Inning, When...

June 10, 2025

CNN Fear and Greed Index Plunges to Extreme...

March 5, 2025

Terms of Reference for Enviromental Study Provided for...

March 26, 2025

Lobo Tiggre: Gold, Silver, Uranium, Copper — Bullish,...

January 29, 2025

AFDG via Butembo Acquisition Becomes First US Public...

October 17, 2025

Convertible Note Financing of up to A$2.0 Million

March 27, 2025

Centurion Minerals: Advancing a High-potential Gold Project in...

December 30, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 4

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 5

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • Terms and conditions
    • Privacy Policy

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved